Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification.
ESMO real world data and digital oncology·2026
[Genetic predisposition to breast cancer].
Annales de chirurgie plastique et esthetique·2025
Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants.
Gynecologic oncology reports·2021
Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
Breast cancer research and treatment·2017